Edwards Lifesciences Cash Flow Statement (2009-2026) | EW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	200.50M	39.90M	54.10M	48.80M	36.60M	26.10M	1.00M	2,707.30M	39.30M	-7.20M	-4.40M	-2.00M	27.00M
Share-based Compensation (Quarter)	30.30M	26.60M	24.20M	32.40M	36.20M	30.30M	27.90M	38.90M	37.40M	32.60M	30.50M	44.60M	43.90M	42.10M	31.70M	40.20M	37.50M	41.20M	39.20M	45.40M
Deferred Taxes (Quarter)	-5.40M	-3.90M	61.50M	42.60M	59.80M	46.30M	105.80M	51.80M	82.90M	46.00M	91.40M	35.80M	66.10M	123.00M	98.50M	24.30M	20.90M	18.00M	54.40M	-9.40M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	-102.60M	1.10M	-18.10M	-20.40M	-20.90M	-12.50M	-58.70M	1.90M	-26.90M		17.70M	-0.50M			-12.70M	-3.60M	-4.70M	-12.50M	-7.90M	-0.50M
Asset Writedowns and Impairment (Quarter)																	47.10M	40.00M	146.90M	123.60M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	526.10M	531.90M	373.60M	293.30M	332.20M	309.90M	282.80M	314.10M	33.60M	411.50M	136.60M	-53.50M	371.50M	351.80M	-127.50M	280.40M	290.20M	573.70M	450.90M	43.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	7.00M	7.10M	7.10M	7.10M	6.80M	6.70M	6.60M	6.80M	6.90M	7.00M	7.50M	7.70M	7.40M	6.50M	6.20M	6.10M	6.40M	6.80M	6.60M	6.50M
Amortization of Deferred Charges (Quarter)	7.00M	7.10M	7.10M
Depreciation & Amortization (CF) (Quarter)	35.80M	33.60M	33.00M	34.70M	34.10M	35.40M	35.40M	35.20M	36.10M	36.90M	36.70M	38.50M	39.60M	34.50M	42.60M	36.60M	38.10M	39.20M	42.70M	40.90M
Change in Working Capital
Change in Receivables (Quarter)	46.40M	-38.00M	-6.80M	57.80M	19.90M	5.30M	1.10M	77.50M	46.80M	-1.30M	18.20M	55.00M	-23.00M	-47.30M	-105.90M	43.70M	24.90M	-13.20M	-32.40M	117.90M
Change in Inventory (Quarter)	-15.00M	-8.10M	6.60M	24.00M	61.80M	65.30M	62.30M	32.80M	80.90M	76.00M	99.30M	69.50M	94.20M	41.20M	51.20M	0.10M	-41.60M	1.80M	-11.00M	1.60M
Change in Accured Expenses (Quarter)	94.10M	79.30M	31.10M	-109.20M	27.50M	26.00M	34.30M	-45.20M	121.40M	36.40M	33.40M	-89.10M	151.80M	29.90M	-3.10M	-103.40M	103.70M	226.10M	168.70M	-347.10M
Change in Taxes (Quarter)	9.10M	5.80M	33.00M	82.90M	-33.20M	-40.90M	-14.40M	87.20M	-56.20M	75.30M	-112.10M	-263.10M	-106.90M	671.80M	-488.50M	51.20M	-240.40M	-10.20M	57.60M	41.90M
Other Working Capital Changes (Quarter)	26.30M	-33.20M	20.00M	-1.70M	-24.00M	65.40M	-39.80M	-6.20M	1.50M	19.50M	67.00M	-27.10M	-13.00M	44.20M	-26.80M	-10.60M	13.90M	14.20M	6.20M	18.10M
Investing Activities
Capital Expenditures (Quarter)	69.30M	60.70M	89.80M	72.70M	43.10M	59.90M	68.90M	61.50M	47.90M	55.30M	88.30M	65.30M	85.40M	51.90M	49.80M	56.00M	49.30M	57.50M	97.40M	64.90M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)								13.10M	0.20M			20.00M		5.40M	4.60M
Acquisitions (Quarter)
Divestments (Quarter)															-3927.40M
Change in Acquisitions & Divestments (Quarter)		212.10M	129.10M	372.00M	-94.50M	-259.50M	921.60M	80.50M	3.00M	403.40M	-389.00M	157.30M	231.10M	150.70M	-481.60M	17.70M	14.30M	2,077.40M	-2047.30M	710.10M
Cash from Investing Activities (Quarter)	-329.50M	-377.40M	-965.90M	229.50M	129.60M	-201.50M	94.70M	0.50M	70.20M	89.00M	14.10M	63.10M	124.80M	2,701.70M	-576.70M	85.30M	-172.10M	-427.80M	-198.30M	-92.80M
Financing Activities
Other financing activities (Quarter)	-0.10M	2.00M	0.70M		-2.00M	-1.90M	0.10M	0.80M	-1.20M	-2.90M	2.00M	-0.20M	7.20M	-10.20M	0.10M	0.70M	1.00M	-2.40M	-3.10M	1.70M
Cash from Financing Activities (Quarter)	-59.00M	39.00M	-62.00M	-368.10M	-308.10M	-69.90M	-838.40M	-206.60M	52.10M	-143.30M	-413.20M	61.70M	-96.60M	-976.70M	28.60M	-258.00M	52.70M	-740.10M	-11.40M	-451.20M
Additional items
Exchange Rate Effect (Quarter)	-2.60M	0.50M	1.80M	13.20M	13.90M	10.30M	-18.20M	-4.20M	15.20M	9.20M	-3.40M	9.70M	29.40M	-51.50M	51.00M	-17.70M	-29.60M	-1.00M	3.50M	8.20M
Change in Cash (Quarter)	135.00M	194.00M	-652.50M	167.90M	167.60M	48.80M	-479.10M	103.80M	171.10M	366.40M	-265.90M	81.00M	429.10M	2,025.30M	-624.60M	90.00M	141.20M	-595.20M	244.70M	-492.00M
Free Cash Flow (Quarter)	456.80M	471.20M	283.80M	220.60M	289.10M	250.00M	213.90M	252.60M	-14.30M	356.20M	48.30M	-118.80M	286.10M	299.90M	-177.30M	224.40M	240.90M	516.20M	353.50M	-21.10M
Net Cash Flow (Quarter)	137.60M	193.50M	-654.30M	154.70M	153.70M	38.50M	-460.90M	108.00M	155.90M	357.20M	-262.50M	71.30M	399.70M	2,076.80M	-675.60M	107.70M	170.80M	-594.20M	241.20M	-500.20M

Research Tools

Edwards Lifesciences Cash Flow Statement (2009-2026) | EW

Create an account

Sign In

Reset Password